An increased hypothermic response to buspirone in patients with major depression

By Navinés Ricard   Gómez-Gil Esther   Martín-Santos Rocío   Martínez de Osaba María   Ímaz Maria   Gastó Cristóbal  

Psychopharmacology, Vol. 188, Iss. 2, 2006-10 ,pp. : 258-260

Springer Publishing Company

Access to resources Recommend Favorite

Gabapentin may be a "valuable tool" for adjunctive therapy among patients with bipolar disorders who are refractory to treatment or who have comorbid psychiatric disorders

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Patients with relapsed or refractory mantle cell lymphoma may receive benefit from bortezomib

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

SSRIs: a homogeneous class of antidepressants with non homogeneous responsiveness in major depression

By Conte G.   Calzeroni A.   Guarneri L.   Pergami A.   Sacchetti E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 299-300

Elsevier

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite